These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 21965276)

  • 1. High-sensitivity C-reactive protein is not a good indicator of infection in patients with systemic lupus erythematosus.
    Amezcua-Guerra LM
    Lupus; 2011 Dec; 20(14):1567-8. PubMed ID: 21965276
    [No Abstract]   [Full Text] [Related]  

  • 2. High-sensitivity C-reactive protein and erythrocyte sedimentation rate in systemic lupus erythematosus.
    Firooz N; Albert DA; Wallace DJ; Ishimori M; Berel D; Weisman MH
    Lupus; 2011 May; 20(6):588-97. PubMed ID: 21436216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there still a place for erythrocyte sedimentation rate and C-reactive protein in systemic lupus erythematosus?
    Dima A; Opris D; Jurcut C; Baicus C
    Lupus; 2016 Oct; 25(11):1173-9. PubMed ID: 27256317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-Reactive protein and its implications in systemic lupus erythematosus.
    de Carvalho JF; Hanaoka B; Szyper-Kravitz M; Shoenfeld Y
    Acta Reumatol Port; 2007; 32(4):317-22. PubMed ID: 18159197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyrexia and normal C-reactive protein (CRP) in patients with systemic lupus erythematosus: always consider the possibility of infection in febrile patients with systemic lupus erythematosus regardless of CRP levels.
    Roy S; Tan KT
    Rheumatology (Oxford); 2001 Mar; 40(3):349-50. PubMed ID: 11285392
    [No Abstract]   [Full Text] [Related]  

  • 6. High-sensitivity C-reactive protein as a marker of cardiovascular risk in systemic lupus erythematosus.
    Nikpour M; Harvey PJ; Ibanez D; Gladman DD; Urowitz MB
    Arthritis Rheum; 2012 Sep; 64(9):3052-3. PubMed ID: 22614710
    [No Abstract]   [Full Text] [Related]  

  • 7. C-reactive protein levels during disease exacerbations and infections in systemic lupus erythematosus: a prospective longitudinal study.
    ter Borg EJ; Horst G; Limburg PC; van Rijswijk MH; Kallenberg CG
    J Rheumatol; 1990 Dec; 17(12):1642-8. PubMed ID: 2084238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies to C-reactive protein in incomplete lupus and systemic lupus erythematosus.
    Jung JY; Koh BR; Kim HA; Jeon JY; Suh CH
    J Investig Med; 2014 Aug; 62(6):890-3. PubMed ID: 24896736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refractory ascites as the first presentation of systemic lupus erythematosus.
    Aljebreen AM; Al-Mogairen SA
    Arab J Gastroenterol; 2014; 15(3-4):161-2. PubMed ID: 25596976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serositis related to systemic lupus erythematosus: prevalence and outcome.
    Man BL; Mok CC
    Lupus; 2005; 14(10):822-6. PubMed ID: 16302677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levels of serum procalcitonin and C-reactive protein for evaluating pulmonary bacterial infection in patients with lupus erythematosus.
    Gao J; Zhang L; Zhang X; Zhao SL; Liu SY; Xing LH
    J Huazhong Univ Sci Technolog Med Sci; 2016 Oct; 36(5):653-658. PubMed ID: 27752903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serositis].
    Korhonen P; Jukka E
    Duodecim; 1999; 115(11):1231-3. PubMed ID: 11877843
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase I, randomized, double-blind, placebo-controlled, multiple intravenous, dose-ascending study of sirukumab in cutaneous or systemic lupus erythematosus.
    Szepietowski JC; Nilganuwong S; Wozniacka A; Kuhn A; Nyberg F; van Vollenhoven RF; Bengtsson AA; Reich A; de Vries DE; van Hartingsveldt B; Robinson DW; Gordon R; Hsu B
    Arthritis Rheum; 2013 Oct; 65(10):2661-71. PubMed ID: 23896980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac involvement in systemic lupus erythematosus not only limited to pericarditis.
    Garg P; Ashrafi R; McKay E; Davis G
    Clin Med (Lond); 2011 Oct; 11(5):507; author reply 507-8. PubMed ID: 22034720
    [No Abstract]   [Full Text] [Related]  

  • 15. Ascites due to lupus peritonitis: a rare form of onset of systemic lupus erythematosus.
    Pott Júnior H; Amate Neto A; Teixeira MA; Provenza JR
    Rev Bras Reumatol; 2012; 52(1):116-9. PubMed ID: 22286651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of correlation between interleukin 6 and C-reactive protein blood levels in systemic lupus erythematosus compared with rheumatoid arthritis.
    Gabay C; Roux-Lombard P; de Moerloose P; Dayer JM; Vischer T; Guerne PA
    J Rheumatol; 1993 May; 20(5):815-21. PubMed ID: 8336307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered glycosylation of complexed native IgG molecules is associated with disease activity of systemic lupus erythematosus.
    Sjöwall C; Zapf J; von Löhneysen S; Magorivska I; Biermann M; Janko C; Winkler S; Bilyy R; Schett G; Herrmann M; Muñoz LE
    Lupus; 2015 May; 24(6):569-81. PubMed ID: 25389233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute systemic lupus erythematosus on the acute medical take: are we missing anything?
    Madan A
    Clin Med (Lond); 2011 Oct; 11(5):507; author reply 507-8. PubMed ID: 22034721
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum procalcitonin and C-reactive protein for differentiating bacterial infection from disease activity in patients with systemic lupus erythematosus.
    Yu J; Xu B; Huang Y; Zhao J; Wang S; Wang H; Yang N
    Mod Rheumatol; 2014 May; 24(3):457-63. PubMed ID: 24252006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generalized subcutaneous edema and polyserositis as unusual presentation in systemic lupus erythematosus.
    Lu L; Zhao Z; Cai H
    Int J Rheum Dis; 2012 Jun; 15(3):e50-2. PubMed ID: 22709501
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.